Market News
Novo Nordisk’s Tough 2026: Obesity Drug Battles Ahead
Novo Nordisk kicked off 2026 with a blockbuster oral obesity pill launch, but lawsuits, disappointing guidance, and fierce competition have...
11/02/2026
3 views